Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 70%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · prior close shown (market closed)
NOVARTIS AG shows decelerating business momentum based on AlphaOS pipeline evidence.
Why it matters: Revenue -1% YoY in Q1 FY2026.
Watch: Dependence on new product growth to offset mature brand declines.
4 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 0d ago
Reported figures for NOVARTIS AG — research only, not investment advice.
Theme: Financial Performance
Updated
What happened recently for NOVARTIS AG (NVS) — events, not interpretation.
Research & analysis only — not investment advice.
Prior close
$150.88
Market cap
$287.90B
Profitable
—
Net income
—
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for NOVARTIS AG — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Connected companies and research pages from the AlphaOS knowledge graph.
Follow NOVARTIS AG through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.